Financial reports
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K/A
2022 FY
Annual report (amended)
25 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
Current reports
8-K
Entry into a Material Definitive Agreement
8 Jan 24
8-K
Departure of Directors or Certain Officers
14 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Jul 23
8-K
Other Events
19 Apr 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Apr 23
8-K
Regulation FD Disclosure
13 Mar 23
8-K
Other Events
2 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Feb 23
8-K
Entry into a Material Definitive Agreement
22 Dec 22
8-K
Humanigen Reports Third Quarter 2022 Financial Results
14 Nov 22
Registration and prospectus
25-NSE
Exchange delisting
12 Oct 23
424B5
Prospectus supplement for primary offering
14 Apr 22
S-3
Shelf registration
1 Mar 22
424B5
Prospectus supplement for primary offering
13 Aug 21
424B5
Prospectus supplement for primary offering
1 Apr 21
424B5
Prospectus supplement for primary offering
29 Mar 21
424B5
Prospectus supplement for primary offering
31 Dec 20
424B3
Prospectus supplement
30 Nov 20
POS AM
Prospectus update (post-effective amendment)
13 Nov 20
424B3
Prospectus supplement
12 Nov 20
Proxies
DEFA14A
Additional proxy soliciting materials
12 Apr 22
DEF 14A
Definitive proxy
12 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
DEF 14C
Information statement
14 Aug 20
PRE 14C
Preliminary information
3 Aug 20
DEF 14C
Information statement
30 Jan 18
PRER14C
Preliminary revised information
22 Jan 18
PRE 14C
Preliminary information
27 Dec 17
DEFA14A
Additional proxy soliciting materials
1 Jun 15
Other
EFFECT
Notice of effectiveness
15 Apr 22
CORRESP
Correspondence with SEC
12 Apr 22
UPLOAD
Letter from SEC
7 Mar 22
EFFECT
Notice of effectiveness
20 Nov 20
CERT
Certification of approval for exchange listing
18 Sep 20
EFFECT
Notice of effectiveness
15 Sep 20
CORRESP
Correspondence with SEC
11 Sep 20
UPLOAD
Letter from SEC
8 Sep 20
EFFECT
Notice of effectiveness
6 Aug 20
CORRESP
Correspondence with SEC
3 Aug 20
Ownership
4
Dale Chappell
20 Oct 23
SC 13G/A
Murchinson Ltd.
1 Feb 23
SC 13G/A
Valiant Capital Management, L.P.
10 Aug 22
4
Cheryl Buxton
29 Jul 22
4
John Hohneker
29 Jul 22
4
RONALD BARLIANT
29 Jul 22
4
Adrian Kilcoyne
29 Jul 22
4
Dale Chappell
29 Jul 22
4
Rainer J. Boehm
29 Jul 22
4
Edward P. Jordan
29 Jul 22